Next Article in Journal
β-Catenin Is a Positive Regulator of Estrogen Receptor-α Function in Breast Cancer Cells
Next Article in Special Issue
NF-kappaB in Lung Tumorigenesis
Previous Article in Journal
Mechanisms and Therapeutic Implications of Cell Death Induction by Indole Compounds
Previous Article in Special Issue
The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
Open AccessReview

Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise

1
Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine. 462 First Avenue, NBV 7N24, New York, NY 10016, USA
2
Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA
*
Author to whom correspondence should be addressed.
Cancers 2011, 3(3), 2975-2989; https://doi.org/10.3390/cancers3032975
Received: 3 June 2011 / Revised: 11 July 2011 / Accepted: 12 July 2011 / Published: 19 July 2011
(This article belongs to the Special Issue Lung Cancer)
Lung cancer is the leading cause of cancer deaths, with an overall survival of 15% at five years. Biomarkers that can sensitively and specifically detect lung cancer at early stage are crucial for improving this poor survival rate. Sputum has been the target for the discovery of non-invasive biomarkers for lung cancer because it contains airway epithelial cells, and molecular alterations identified in sputum are most likely to reflect tumor-associated changes or field cancerization caused by smoking in the lung. Sputum-based molecular biomarkers include morphology, allelic imbalance, promoter hypermethylation, gene mutations and, recently, differential miRNA expression. To improve the sensitivity and reproducibility of sputum-based biomarkers, we recommend standardization of processing protocols, bronchial epithelial cell enrichment, and identification of field cancerization biomarkers. View Full-Text
Keywords: lung cancer; non-small cell lung cancer; sputum; biomarker; early detection lung cancer; non-small cell lung cancer; sputum; biomarker; early detection
MDPI and ACS Style

Kim, C.E.; Tchou-Wong, K.-M.; Rom, W.N. Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise. Cancers 2011, 3, 2975-2989.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop